8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Prognostic Value of Machine‐Learning‐Based PRAISE Score for Ischemic and Bleeding Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          The PRAISE (Prediction of Adverse Events Following an Acute Coronary Syndrome) score is a machine‐learning‐based model for predicting 1‐year all‐cause death, myocardial infarction, and Bleeding Academic Research Consortium (BARC) type 3/5 bleeding. Its utility in an unselected Asian population undergoing percutaneous coronary intervention for acute coronary syndrome remains unknown. We aimed to validate the PRAISE score in a real‐world Asian population.

          Methods and Results

          A total of 6412 consecutive patients undergoing percutaneous coronary intervention for acute coronary syndrome were prospectively included. The PRAISE scores were compared with established scoring systems (GRACE [Global Registry of Acute Coronary Events] 2.0, PRECISE‐DAPT (Predicting Bleeding Complications in Patients Undergoing Stent Implantation and Subsequent Dual Antiplatelet Therapy), and PARIS [Patterns of Non‐Adherence to Anti‐Platelet Regimen in Stented Patients]) to evaluate their discrimination, calibration, and reclassification. The risk of all‐cause mortality (hazard ratio [HR], 12.24 [95% CI, 5.32–28.15]) and recurrent acute myocardial infarction (HR, 3.92 [95% CI, 1.76–8.73]) was greater in the high‐risk group than in the low‐risk group. The C‐statistics for death, myocardial infarction, and major bleeding were 0.75 (0.67–0.83), 0.61 (0.52–0.69), and 0.62 (0.46–0.77), respectively. The observed to expected ratio of death, myocardial infarction, and major bleeding was 0.427, 0.260, and 0.106, respectively. Based on the decision curve analysis, the PRAISE score displayed a slightly greater net benefit for the 1‐year risk of death (5%–10%) than the GRACE score did.

          Conclusions

          The PRAISE score showed limited potential for risk prediction in our validation cohort with acute coronary syndrome. As a result, new prediction models or model refitting are required with improved discrimination and accuracy in risk prediction.

          Related collections

          Most cited references29

          • Record: found
          • Abstract: not found
          • Article: not found

          2018 ESC/EACTS Guidelines on myocardial revascularization

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization.

            The ability to parse tumors into subsets based on biomarker expression has many clinical applications; however, there is no global way to visualize the best cut-points for creating such divisions. We have developed a graphical method, the X-tile plot that illustrates the presence of substantial tumor subpopulations and shows the robustness of the relationship between a biomarker and outcome by construction of a two dimensional projection of every possible subpopulation. We validate X-tile plots by examining the expression of several established prognostic markers (human epidermal growth factor receptor-2, estrogen receptor, p53 expression, patient age, tumor size, and node number) in cohorts of breast cancer patients and show how X-tile plots of each marker predict population subsets rooted in the known biology of their expression.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement

                Bookmark

                Author and article information

                Contributors
                songweihua@fuwai.com , dongqiuting@fuwai.com
                songweihua@fuwai.com
                Journal
                J Am Heart Assoc
                J Am Heart Assoc
                10.1002/(ISSN)2047-9980
                JAH3
                ahaoa
                Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
                John Wiley and Sons Inc. (Hoboken )
                2047-9980
                28 March 2023
                04 April 2023
                : 12
                : 7 ( doiID: 10.1002/jah3.v12.7 )
                : e025812
                Affiliations
                [ 1 ] Cardiometabolic Medicine Center, Department of Cardiology, Fuwai Hospital Chinese Academy of Medical Sciences & Peking Union Medical College/National Center for Cardiovascular Diseases Beijing China
                [ 2 ] Coronary Heart Disease Center, Department of Cardiology, Fuwai Hospital Chinese Academy of Medical Sciences & Peking Union Medical College/National Center for Cardiovascular Diseases Beijing China
                [ 3 ] State Key Laboratory of Cardiovascular Disease Beijing China
                [ 4 ] National Clinical Research Center for Cardiovascular Diseases Beijing China
                Author notes
                [*] [* ]Correspondence to: Weihua Song, MD, PhD and Qiuting Dong, MD, PhD, Cardiometabolic Medicine Center & Coronary Heart Disease Center, Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 10037, China. Email: songweihua@ 123456fuwai.com and dongqiuting@ 123456fuwai.com
                [*]

                B. Shi and H. Y. Wang contributed equally and are co‐first authors.

                Author information
                https://orcid.org/0000-0002-3403-9128
                https://orcid.org/0000-0002-5634-0966
                https://orcid.org/0000-0002-9956-7511
                https://orcid.org/0000-0001-9358-5826
                https://orcid.org/0000-0002-8372-6338
                Article
                JAH38314 JAHA/2022/025812
                10.1161/JAHA.122.025812
                10122888
                36974761
                317db1b0-e326-4d0c-83c6-28f7de6fc555
                © 2023 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

                History
                : 17 February 2022
                : 23 February 2023
                Page count
                Figures: 3, Tables: 3, Pages: 10, Words: 5629
                Funding
                Funded by: Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences
                Award ID: 2020‐I2M‐C&T‐B‐056)
                Award ID: 2021‐I2M‐1‐008
                Funded by: Prevention and Control Projects of the Major Chronic Noninfectious Disease
                Award ID: 2018YFC1315600
                Categories
                Original Research
                Original Research
                Coronary Heart Disease
                Custom metadata
                2.0
                04 April 2023
                Converter:WILEY_ML3GV2_TO_JATSPMC version:6.2.7 mode:remove_FC converted:10.04.2023

                Cardiovascular Medicine
                acute coronary syndrome,machine learning,praise score,risk stratification

                Comments

                Comment on this article